Abedelnasser Abulrob
#184,411
Most Influential Person Now
Researcher
Abedelnasser Abulrob's AcademicInfluence.com Rankings
Abedelnasser Abulrobcomputer-science Degrees
Computer Science
#12995
World Rank
#13936
Historical Rank
Machine Learning
#6046
World Rank
#6148
Historical Rank
Artificial Intelligence
#6508
World Rank
#6628
Historical Rank
Database
#10147
World Rank
#10771
Historical Rank

Download Badge
Computer Science
Why Is Abedelnasser Abulrob Influential?
(Suggest an Edit or Addition)According to Wikipedia, Abedelnasser Abulrob is a British-born medical researcher specialising in the areas of cancer therapeutics and personalized medicine. He held several senior level positions at the National Research Council of Canada, and is currently an adjunct Professor at the Faculty of Medicine-University of Ottawa in Canada.
Abedelnasser Abulrob's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Metastasis-associated Protein S100A4 Induces Angiogenesis through Interaction with Annexin II and Accelerated Plasmin Formation* (2005) (231)
- The blood–brain barrier transmigrating single domain antibody: mechanisms of transport and antigenic epitopes in human brain endothelial cells (2005) (176)
- Interactions of EGFR and caveolin-1 in human glioblastoma cells: evidence that tyrosine phosphorylation regulates EGFR association with caveolae (2004) (137)
- Constitutive Expression of P-Glycoprotein in Normal Lung Alveolar Epithelium and Functionality in Primary Alveolar Epithelial Cultures (2003) (100)
- Effect of the anti-receptor ligand-blocking 225 monoclonal antibody on EGF receptor endocytosis and sorting. (2006) (96)
- Low-temperature approach to highly emissive copper indium sulfide colloidal nanocrystals and their bioimaging applications. (2013) (92)
- Nanoscale Imaging of Epidermal Growth Factor Receptor Clustering (2009) (90)
- Caveolae: An Alternative Membrane Transport Compartment (2000) (84)
- Influence of glioma tumour microenvironment on the transport of ANG1005 via low-density lipoprotein receptor-related protein 1 (2011) (79)
- Kinetic analysis of novel mono‐ and multivalent VHH‐fragments and their application for molecular imaging of brain tumours (2010) (75)
- Label-free impedimetric immunosensor for ultrasensitive detection of cancer marker Murine double minute 2 in brain tissue. (2013) (75)
- Evaluation of brain tumor vessels specific contrast agents for glioblastoma imaging. (2012) (70)
- Protection by cholesterol‐extracting cyclodextrins: a role for N‐methyl‐d‐aspartate receptor redistribution (2005) (66)
- Transport characteristics of a novel peptide platform for CNS therapeutics (2009) (60)
- Identification and biological evaluation of grapefruit oil components as potential novel efflux pump modulators in methicillin-resistant Staphylococcus aureus bacterial strains. (2004) (55)
- Dynamic Analysis of the Blood-Brain Barrier Disruption in Experimental Stroke Using Time Domain in Vivo Fluorescence Imaging (2008) (54)
- Molecular imaging of glioblastoma multiforme using anti-insulin-like growth factor-binding protein-7 single-domain antibodies (2010) (50)
- In Vivo Time Domain Optical Imaging of Renal Ischemia-Reperfusion Injury: Discrimination Based on Fluorescence Lifetime (2007) (38)
- In vivo imaging of brain cancer using epidermal growth factor single domain antibody bioconjugated to near-infrared quantum dots. (2014) (34)
- The Effect of Fatty Acids and Analogues upon Intracellular Levels of Doxorubicin in Cells Displaying P-Glycoprotein Mediated Multidrug Resistance (2000) (32)
- Small unilamellar vesicles: a platform technology for molecular imaging of brain tumors (2011) (31)
- In vivo optical imaging of ischemic blood-brain barrier disruption. (2011) (23)
- Integrated platform for brain imaging and drug delivery across the blood-brain barrier. (2011) (22)
- Antisense oligonucleotides: absorption, distribution, metabolism, and excretion (2021) (19)
- Near‐field scanning optical microscopy detects nanoscale glycolipid domains in the plasma membrane (2008) (16)
- In Vivo Near-Infrared Fluorescence Imaging of Atherosclerosis Using Local Delivery of Novel Targeted Molecular Probes (2019) (16)
- Comparison of T2 and T2*-weighted MR molecular imaging of a mouse model of glioma (2013) (15)
- Molecular susceptibility weighted imaging of the glioma rim in a mouse model (2014) (14)
- Perspectives in Molecular Imaging Using Staging Biomarkers and Immunotherapies in Alzheimer's Disease (2013) (14)
- Optimal dye-quencher pairs for the design of an "activatable" nanoprobe for optical imaging. (2013) (13)
- Single domain antibodies as blood–brain barrier delivery vectors (2005) (13)
- In vitro and in vivo methods for assessing FcRn-mediated reverse transcytosis across the blood-brain barrier. (2011) (12)
- LyP-1 Conjugated Nanoparticles for Magnetic Resonance Imaging of Triple Negative Breast Cancer (2018) (10)
- Detection of T(2) changes in an early mouse brain tumor. (2010) (10)
- Validating Intravascular Imaging with Serial Optical Coherence Tomography and Confocal Fluorescence Microscopy (2016) (9)
- Development of an Anti-Vascular Cell Adhesion Protein-1 Aptamer for Molecular Imaging and Inflammation Detection in Transgenic Mouse Model of Alzheimer's Disease. (2015) (7)
- 117 POSTER ANG1005, Paclitaxel conjugated to the angiopep brain transport vector for the treatment of brain cancer: preclinical studies (2008) (2)
- ET-09 : A new drug, ANG1005, a conjugate of Paclitaxel and Angiopep peptide vector able to cross the Blood-Brain Barrier for the treatment of brain cancers. (2008) (2)
- P4-245 Nanobodies™ targeting amyloid beta as potential therapeutics for Alzheimer’s disease (2006) (1)
- Site‐specific conjugation of the quencher on peptide's N‐terminal for the synthesis of a targeted non‐spreading activatable optical probe (2016) (1)
- THU0073 14-3-3ETA as a Novel RA Drug Target: Anti-14-3-3ETA Monoclonal Antibody Delays the Onset and Mitigates the Severity of Arthritis in CIA MICE (2015) (1)
- AB0152 14-3-3Eta Biomarker Dynamics in CIA Mark Disease Severity in A Non-Interventional Study (2014) (1)
- Molecular Imaging of Brain Tumours Using Single Domain Antibodies (2012) (1)
- P4-279 Target specificity of nanobodies™ directed against amyloid peptides (2006) (1)
- Molecular and Functional Characterization of Caveolae in Mixed Cultures of Human NT-2 Neurons and Astrocytes (2021) (1)
- In Vivo Near-Infrared Fluorescence Imaging of Atherosclerosis Using Local Delivery of Novel Targeted Molecular Probes (2019) (0)
- P685In vivo near-infrared fluorescence (NIRF) molecular imaging of atherosclerosis (2017) (0)
- The ex vivo and in vivo MR Study of Glioma Targeted Contrast Agents (2008) (0)
- Correction to: LyP-1 Conjugated Nanoparticles for Magnetic Resonance Imaging of Triple Negative Breast Cancer (2018) (0)
- Targeted MRI and optical molecular imaging using gadolinium loaded small unilamellar vesicles (2011) (0)
- In vivo T 2 Measurements of Glioma Growth in Mouse Brain at 9 . 4 T (2008) (0)
- BIMODAL INTRAVASCULAR ULTRASOUND (IVUS)/NEAR-INFRARED FLUORESCENCE (NIRF) MOLECULAR IMAGING OF ATHEROSCLEROTIC RABBITS (2016) (0)
- INHIBITORS Factor Receptor Clustering : EFFECTS OF Nanoscale Imaging of Epidermal Growth Mechanisms of Signal Transduction : (2010) (0)
- ANG1005, a new therapeutic drug able to cross the blood-brain barrier for the treatment of brain cancers. (2008) (0)
- NI-08OPTIMIZATION OF MOLECULAR MR IMAGING OF GLIOMA. (2014) (0)
- Cerebrospinal fluid biomarkers for assessing Huntington disease onset and severity (2022) (0)
- Titre : Title : Validating intravascular imaging with serial optical coherence tomography and confocal fluorescence microscopy (2018) (0)
This paper list is powered by the following services:
Other Resources About Abedelnasser Abulrob
What Schools Are Affiliated With Abedelnasser Abulrob?
Abedelnasser Abulrob is affiliated with the following schools: